Logo
Login
$BRKR
$58.23 +$0.64 (1.11%) Close

Company Executives

$BRKR Management Team

Dr. Mark Munch

Executive Vice President

President of Bruker Nano Group and Bruker Nano Surfaces Division

Age 63
Compensation $2.642M USD
Sex Male

Dr. Frank Laukien

Chairman of the Board

President

Chief Executive Officer

Age 65
Compensation $5.527M USD
Sex Male

Mr. Gerald Herman

Chief Financial Officer

Executive Vice President

Age 67
Compensation $2.288M USD
Sex Male

Dr. Falko Busse

President - Bruker BioSpin Group

Age 58
Compensation $1.465M USD
Sex Male

Dr. Burkhard Prause

President and Chief Executive Officer - Bruker Energy and Supercon Technologies

Inc

Age 58
Compensation $967.9K USD
Sex Male

Mr. Juergen Srega

President of Bruker CALID Group and Bruker Daltonics Division

Age 70
Compensation $1.522M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 10, 2026
Directors
11
serving now
Independent
10 of 11
stated in the proxy
Average tenure
11.7 years
from year joined
CEO also chairs the board
Yes
Frank H. Laukien, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
John J. (Jack) Phillips
60 2026
0 years
 Independent
Compensation Committee
None stated Not stated
Hermann F. Requardt, Ph.D.
71 2015
11 years
 Independent
Compensation Committee
None stated Not stated
Laura A. Francis
59 2025
1 year
 Independent
Audit Committee
None stated $243,349
Thierry L. Bernard
61 2026
0 years
 Independent None stated Neogen Corporation Not stated
William A. Linton, Ph.D.
78 2000
26 years
 Independent
Nominating & Governance Committee
None stated Not stated
Adelene Q. Perkins
66 2017
9 years
 Independent
Nominating & Governance Committee · Chair
None stated $252,032
Robert J. Rosenthal, Ph.D.
69 2015
11 years
 Independent
Audit Committee Compensation Committee
Safeguard Scientifics, Inc. Not stated
Bonnie H. Anderson
68 2020
6 years
 Independent
Compensation Committee · Chair Nominating & Governance Committee
None stated $258,449
Frank H. Laukien, Ph.D.
Board chair, CEO
 66 1991
35 years
 Not independent None stated None stated Paid as CEO
John A. Ornell
68 2015
11 years
 Independent
Audit Committee · Chair
None stated $272,532
Richard A. Packer
Lead independent director
 68 2007
19 years
 Independent
Nominating & Governance Committee
None stated $263,365

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

9 disclosed in the proxy filed Apr 10, 2026
Dr. Dirk Laukien, Mr. Joerg Laukien and Ms. Laukien-Kleiner (co-owners of ZeroC Project GmbH)
half-brother, brother and stepmother of Dr. Frank H. Laukien
$292,896
2025

Bruker BioSpin AG rents a property in Faellanden, Switzerland from ZeroC Project GmbH under a lease agreement

With Bruker BioSpin AG Open in proxy
Promega Corporation
Dr. William A. Linton, a director of the Company, is Chairman, President, and Chief Executive Officer of Promega Corporation
Amount not stated
2025

Equipment sales to and purchases from Promega Corporation in the ordinary course of business

With the Company Open in proxy
Dr. Frank H. Laukien
EUR 2.8 million (approximately $3.1 million)
2025

Purchased 687,500 shares of Gauss Fusion GmbH from Bruker EAS GmbH, a wholly owned subsidiary of the Company

With Bruker EAS GmbH Open in proxy
Dr. Frank H. Laukien
EUR 2.7 million (approximately $3.1 million)
2025

Convertible loan agreement to Gauss Fusion GmbH

With Gauss Fusion GmbH Open in proxy
Two immediate family members of Dr. Frank H. Laukien
immediate family members of Dr. Frank H. Laukien
EUR 0.6 million (approximately $0.7 million)
2025

Collectively contributed additional funds to Gauss Fusion GmbH alongside Dr. Laukien's convertible loan

With Gauss Fusion GmbH Open in proxy
Asahi Kasei Corporation
Mr. Richard A. Packer, a director of the Company, is a Vice Presidential Executive Officer of Asahi Kasei Corporation
$155,383
2025

Equipment sales in the ordinary course of business to Asahi Kasei Corporation

With the Company Open in proxy
Dr. Meike Hamester
wife of Juergen Srega, the President of Bruker CALID Group
$235,148
2025

Employment with Bruker Daltonik GmbH as VP & Managing Director of Bruker Biosensors, with total compensation

With Bruker Daltonik GmbH Open in proxy
Dr. Venita Busse
wife of Falko Busse, the President of Bruker BioSpin Group
$237,112
2025

Employment with Bruker Switzerland AG as Director of Group Strategy Development, with total compensation

With Bruker Switzerland AG Open in proxy
Dr. Venita Busse
wife of Falko Busse, the President of Bruker BioSpin Group
Approximately $185,238
2026

Expected total compensation upon separation from the Company effective June 30, 2026

With Bruker Switzerland AG Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans